Emerging Company Profile

Concarlo: targeting proliferation and resistance in one go

SUNY Downstate spinout takes aim at metastatic breast cancer by targeting p27

By targeting p27, SUNY Downstate spinout Concarlo simultaneously takes aim at mechanisms of proliferation and resistance in cancer, starting with metastatic breast cancer. 

Concarlo is developing targeted therapies